Over the last 12 months, Shattuck Labs insiders reported 1 buy totaling $250K and 3 sales totaling $379K across SEC Form 4 filings. 75% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Shukla Abhinav A.Chief Technical Officer · O | ▼ Sale | 410 | $7.01 | $3K | -0.5% | plan |
| Jul 1, 2026 | Shukla Abhinav A.Chief Technical Officer · O | ▼ Sale | 23,465 | $7.08 | $166K | -21.4% | plan · 2 tranches |
| Jun 30, 2026 | Pandite Arundathy N.Chief Medical Officer · O | ▼ Sale | 30,000 | $7.01 | $210K | -18% | plan |
| Jun 9, 2026 | SIEGALL CLAY BD | ▲ Buy | 62,500 | $4 | $250K | +24.4% | — |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $STTK feed.